Chemoinformaics analysis of (5E,7E)-dodeca-5,7-diene
Molecular Weight | 166.308 | nRot | 7 |
Heavy Atom Molecular Weight | 144.132 | nRig | 2 |
Exact Molecular Weight | 166.172 | nRing | 0 |
Solubility: LogS | -3.665 | nHRing | 0 |
Solubility: LogP | 4.287 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 34.7094 |
nHD | 0 | BPOL | 22.0706 |
QED | 0.386 |
Synth | 2.457 |
Natural Product Likeliness | 1.306 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.449 |
MDCK | 0.0000255 |
BBB | 0.742 |
PPB | 0.95322 |
VDSS | 1.094 |
FU | 0.0386287 |
CYP1A2-inh | 0.952 |
CYP1A2-sub | 0.858 |
CYP2c19-inh | 0.778 |
CYP2c19-sub | 0.866 |
CYP2c9-inh | 0.492 |
CYP2c9-sub | 0.983 |
CYP2d6-inh | 0.84 |
CYP2d6-sub | 0.927 |
CYP3a4-inh | 0.582 |
CYP3a4-sub | 0.172 |
CL | 3.846 |
T12 | 0.268 |
hERG | 0.225 |
Ames | 0.017 |
ROA | 0.026 |
SkinSen | 0.931 |
Carcinogencity | 0.146 |
EI | 0.983 |
Respiratory | 0.725 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.756214 |